TrialAIDS research and therapy2026

B/F/TAF in people with both HIV-1 and hepatitis B: outcomes from the ALLIANCE open-label extension phase.

Anchalee Avihingsanon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.